• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Australia Product Image

IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Australia

  • ID: 1408472
  • June 2015
  • Region: Australia
  • 64 Pages
  • IMS Health

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets. This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Note: Product cover images may vary from those shown

Australia

1. Healthcare System
- Facts & Figures
- Market Indicators
- Provision & Funding
- Medicare
- Private Insurance
- Healthcare Services

2. Pricing
- Prescription Drugs
- Background
- Current Pricing Procedure
- Pricing Mechanisms
- Generic Drugs
- Hospital Drugs
- Background
- Reform
- OTC Drugs

3. Reimbursement
- Admission to Reimbursement
- Background
- Application Process
- Listing Recommendations
- Reform
- Formularies
- Reimbursement Restrictions
- Timelines
- Independent Reviews
- Reimbursement Categories
- Reimbursement Prices
- Hospital Reimbursement
- Formularies
- Funding
- Changes in Reimbursement Status
- Minor Changes
- Major Changes
- Other Changes
- Changes in Reimbursement Prices
- Price Reviews
- Price Cuts
- Price Disclosure
- Memorandum of Understanding

4. Pharmacoeconomics
- Pharmacoeconomic Requirements
- Pharmaceutical Benefits Scheme
- Hospital Formularies

5. Price Build Up
- Wholesalers
- Mark-ups
- CSO Funding Pool
- Background
- Retail Pharmacies
- Pharmacy Margins
- Background
- Dispensing Doctors
- Sales Tax

6. Cost Containment
- Industry Paybacks
- Promotional Costs
- Expenditure
- Controls over Advertising and Promotion
- Patient Co-payments
- Pharmaceuticals
- Healthcare
- Prescribing Controls
- National Prescribing Service
- Hospital Prescribing
- Reimbursement Restrictions
- E-Health Strategy
- Generics
- Substitution
- Promotion
- INN Prescribing
- Rx-to-OTC Switches
- Switch Procedure
- Recent Switches
- Other Changes of Status
- OTC Market
- Parallel Trade

7. Future Developments
- Outlook
- Package of PBS Reforms
- Federal Budget for 2015-2016
- “Healthier Medicare” Initiative
- Medication Chart
- PBAC Reform

8. Names & Addresses

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S